Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)
Clinical trial NCT01851330 · COMPLETED
Trial details
- NCT number
- NCT01851330
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-12-01
- Enrollment
- 647
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.